buy-hgh-secretagogue-hgh-herbal-releaser
 

Herbal Human Growth Hormone releaser re-ignites your fires-of-youth: Naturally! 

"ReBuilding-Your-Body 'Esp.if you're OVER 35 y.o.' via HGH Antiaging"

Comment:
Dear reader,
As you may be aware this antiaging site is all about anti-fibrosis or Anti-scarring or Anti-adhesions as our answer to THE age-old antiaging mystery of all time.

For we have discovered powerful antiaging effects occur when scarring is broken down.

However the actual research news item to which the article below refers was put-to-air-a few months earlier during the second week of the Beijing olympics in Aug 2008.
In fact so important was the radio item that it was broadcast over 2 consecutive nights in our local news in Australia. However it seems no-one really heard it because the the Olympics 'drowned-it-out'.

Nevertheless I heard it LOUD & CLEAR! You see I too was in the throes of perfecting my own antifibrosis-antiaging herbal pack you now see featured on this site.

In summary, the REALLY critical thing to draw from this article below is the 45% of disease figure the reaerchers quote that fibrosis is involved in.

NOW FOLKS, please remember, medical researchers are famous for their conservatism & understatements. They continually 'downplay' any sort of HUGE numbers like this!!! So to actually broadcast publically these-sort-of-percentages says to you that either they are going 'crazy' OR have really 'hit pay-dirt'.

In truth it is ABSOLUTELY STUNNING in its merit AND broad reach for researchers to talk in these HUGE, HUGE, HUGE numbers when referring to treating disease- ANY DISEASE!

So PLEASE: Read this item below with the'jawdropping' REAL IMPORT that it FULLY DESERVES!

We suggest that 'this article' figure of 45% is VERY, VERY conservative & in light of our research would put it MUCH higher; We estimate that at least 60% of chronic disease is either caused by fibrosis or complicated because of it.

 

News Release #1

Melbourne Australia: Tuesday, 28 October 2008
A $3 million investment to progress a Victorian-developed drug that prevents the spread of fibrosis was announced today at Ausbiotech 2008 in Melbourne.
Premier John Brumby said the Medical Research Commercialisation Fund backed by the Victorian, NSW and West Australian Governments with investment funding from the Statewide and Westscheme Superannuation funds has invested $3 million to bring the drug, FT-11, to commercial reality.

“This investment will help to ensure a Victorian discovery becomes a worldwide success,” Mr Brumby said.

“FT-11 is a breakthrough for treating fibrotic conditions that are responsible for up to 45 per cent of all deaths in the Western world."

“What this investment means is that scientists from the University of Melbourne and the Bio21 Institute can continue the development of this drug here in Australia. There is enormous international interest in the news that Victorian scientists had developed a novel drug for the treatment of fibrosis."

“Fibrosis – the irreversible scarring of vital organs – underpins many major killers such as kidney disease, heart failure, diabetes and lung and liver problems.”

The University of Melbourne shares patent rights for the drug through Fibrotech Therapeutics, the company commercialising the drug. The University’s commercialisation company, Melbourne Ventures, has also worked closely with Fibrotech on its commercial and strategic development, under a program supported by the Brumby Government through its Vicstart initiative.

The drug will initially be developed to treat people with kidney disease caused by diabetes.

Fibrotech’s Associate Professor Darren Kelly said: “The Melbourne project has had a 100 per cent success rate in trials on rats and will be trialled on approximately 30 Victorian patients. Depending on the results of clinical trials, the drug could be available within six to eight years.”

Fibrosis plays a major part in the disease’s progression but studies suggest that this therapy could slow the progression of the disease. There are currently 10,000 Australians on dialysis and any drug that can stop the scarring to the kidney would be a major advance.

Innovation Minister Gavin Jennings said: “The investment by the Medical Research Commercial Fund is a great example of how a venture capital fund can work with our premier research institutions to take their ideas to the world while ensuring the best commercial outcome for Victoria.”

Dr Chris Nave, the co-founder of the Medical Research Commercial Fund, said: "Our aim is to help researchers to progress technologies from the laboratory to the bedside and we are delighted that our investment in this technology will help to develop a therapy, which could potentially help millions of people throughout the world.”

resource-partners

Bookmark this page
Blogmarks Digg Facebook Furl Google Bookmarks Livejournal Ma.gnolia Reddit Spurl Stumbleupon Technorati Yahoo My Web


 

 © Copyright www.buyhghsecretagogue.com, 2009-2010. All Rights Reserved. 

Disclaimer: The products and the descriptions made about specific products on or through this site have not been evaluated by the US FDA OR the Australian TGA and are not approved to diagnose, treat, cure or prevent disease.
The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging.
You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. Also you should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.